A critical analysis of soluble interleukin-2 receptor levels in kidney allograft recipients

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Kaden, J ^a   Schutze B ^b   May, G ^a  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^b DPC Biermann   (Germany)

Author keywords

Interleukin 2 receptor; Interleukin 6; Kidney transplantation; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CADAVER KIDNEY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029979864     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01688.x     Document Type: Article

References (29)

1. Barton DPJ, Blanchard DK, Michelini-Norris B, Roberts WS, Hoffman MS, Fiorica JV, Nicosia SV, Cavanagh D, Djeu JY (1993) Serum soluble interleukin-2 receptor α levels in patients with gynecologic cancers: Early effect of surgery. Amer J Reprod Immunol 30: 202-206
2. Bock GH, Neu L, Long C, Patterson LT, Korb S, Gelpi J, Nelson DL (1994) An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection. Am J Kidney Dis 23: 421-426
3. Chopra RK, Powers DC, Kendig NE, Adler WH, Nagel JE (1989) Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation. Immunol Invest 18: 961-973
4. Colvin RB, Fuller TC, MacKeen L, Kung PC, Ip SH, Cosimi AB (1987) Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol 43: 273-276
5. Colvin RB, Preffer FI, Fuller TC, Brown MC, Ip SH, Kung PC, Cosini AB (1989) A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients. Transplantation 48: 800-804
6. Forsythe JLR, Shenton BK, Parrott NR, Taylor RMR, Proud G (1989) Plasma interleukin 2 receptor levels in renal allograft dysfunction. Transplantation 48: 155-157
7. Fraunberger P, Pfeiffer M, Haller M, Hoffmann RM, Zwiebel FM, Überfuhr P, Jauch KW, Nagel D, Walli AK, Seidel D (1995) Cytokine and cytokine-receptor profiles after liver and heart transplantation. Transplant Proc 27: 2023-2027
8. Hacini J, Berthoux F, Berthoux P, Vindimian M, Lambert C, Laurent B, Alamartine E, Guérin C (1992) Monitoring of serum cytokines in renal transplantation: respective value of neopterin (N), soluble interleukin 2 receptor (sIL-2R), and tumor necrosis factor alpha (TNFα) in the different clinical situation. In: Touraine JL, Traeger J, Bétuel H, Dubernard JM, Revillard JP, Dupuy C (eds) Transplantation and clinical immunology XXIV. Elsevier Science Publishers, Amsterdam London New York, pp 165-169
9. Humbert M, Emilie D, Cerrina J, Simonneau G, Rain B, Fattal S, Le Roy Ladurie F, Dartevelle P, Duroux P, Galanaud P (1991) Soluble interleukin 2 receptor and neopterin serum levels after lung/heart - lung transplantations - absence of predictive value for late allograft rejection. Transplantation 52: 1092-1094
10. Ippoliti G (1995) Behavior of serum cytokine levels and peripheral lymphocyte subsets after H-LTx. Transplant Proc 27: 2021-2022
11. Ippoliti G, Vinante F, Rovati B, Di Franco L, Martinelli L, Goggi C, Viganó M, Pizzolo G (1990) Serum levels of soluble interleukin-2 receptor (sIL-2R) fail to correlate with the occurrence and degree of rejection in heart transplant patients. Clin Transplant 4: 1-4
12. Jutte NHPM, Hesse CJ, Balk AHMM, Mochtar B, Weimar W (1990) Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients. Transplantation 50: 328-330
13. Kaden J, May G, Schönemann C, Müller P, Groth J, Seeger W, Seibt F, Henkert M, Lippert J (1992) Effect of ATG prophylaxis in sensitized and non-sensitized kidney graft recipients. Transplant Int 5 [1]: 75-78
14. Kaden J, May G, Müller P, Groth J, Strobelt V, Eger E, Wohlfahrt L (1995) Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival. Transplant Proc 27: 1060-1061
15. Kaden J, Willsch C, Spehr V, Kaden K, Strobelt V, May G (1995) Nachweis und diagnostische Wertigkeit von IL-8 im Harn von Nierentransplantatempfängern. Transplant Med 7: 114-122
16. Köhler H, Girndt M, Dumann H, Klingel R (1993) Immundefekt bei Niereninsuffizienz. II. Mechanismen des "urämischen" Immundefekts. Dtsch Med Wochenschr 118: 790-795
17. Lahat N, Shtiller R, Zlotnick AY, Merin G (1993) Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness. Clin Exp Immunol 92: 482-486
18. Langhoff E, Ladefoged J, Odum N (1986) Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes. Int Arch Allegy Appl Immunol 81: 5-11
19. Malcus C, Pouteil-Noble C, Touraine F, Raffaele P, Touraine JL (1990) Plasma soluble interleukin-2 receptor (IL-2Rs) level and activation markers in blood in the follow-up of renal allograft patients. Transplant Proc 22: 1865-1866
20. Perkins JD, Munn SR, Barr D, Ferguson DC, Carpenter HA (1990) Evidence that the soluble interleukin 2 receptor level may determine the optimal time for cystoscopically directed biopsy in pancreatico-duodenal allograft recipients. Transplantation 49: 363-366
21. Pizzolo G (1988) The soluble interleukin-2 receptor as a new biological marker in diseases. Immunol Clin 7: 13-21
22. Plaza JJ, Blum G, Ortiz A, Hernando L, Feijoo E, Sanz J, Garcia R, Egido J, Ortiz F (1992) Usefulness of serum interleukin 2 receptor levels in renal allograft recipients. Transplant Proc 24: 63-64
23. Pollak R, Fabrega AJ, Vasquez E, Sanchez J, Mulero CB, Williams RH (1995) Measurement of serum-soluble interleukin 2 receptor levels following renal transplantation. Transplantation 59: 926-927
24. Raskova J, Ghobrial I, Shea SM, Ebert EC, Eisinger RP, Raska K (1986) T cells in patients undergoing chronic hemodialysis: Mitogenic response suppressor activity and interleukin-2 production and receptor generation. Diagn Immunol 4: 209-216
25. Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR, Muth KL (1992) A multicenter study to evaluate a novel assay for quantification of soluble interleukin 2 receptor in renal transplant recipients. Transplantation 53: 34-40
26. Simpson MA, Madras PN, Cornaby AJ, Etienne T, Dempsey RA, Clowes GHA, Monaco AP (1989) Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation 47: 218-223
27. Stockenhuber F, Steininger R, Apperl A, Muehlbacher F, Patek E, Sautner T, Sertl K, Graninger W, Hauser AC, Balcke P (1990) Soluble interleukin-2 receptor: A novel parameter of renal graft rejection. Transplant Proc 22: 165-166
28. Tice DG, Heintz S, Scruggs B, Hubbell C, Szmalc FS (1993) Immune monitoring: Does the reality fulfill the promise? Transplant Proc 25: 2654
29. Young JB, Lloyd KS, Windsor NT, Cocanougher B, Weilbaecher DG, Kleiman NS, Smart FW, Nelson DL, Lawrence EC (1991) Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy. J Heart Lung Transplant 10: 243-250